This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Stella Pharma Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Yoshiya Iguchi: Innovator in Boron Neutron Capture Therapy
Introduction
Yoshiya Iguchi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical technology, particularly in the area of boron neutron capture therapy. His innovative work has the potential to enhance cancer treatment options.
Latest Patents
Yoshiya Iguchi holds a patent for an injection solution containing p-boronophenylalanine. The objective of this invention is to provide an effective injection solution for boron neutron capture therapy. The solution comprises p-boronophenylalanine or a pharmaceutically acceptable salt, with a boron atom ratio of 75% or more. Additionally, it includes a sugar alcohol, an antioxidant, and water, maintaining a pH of 6.5 to 7.8 and an osmotic pressure ratio of 1.0 to 1.8. This injection solution is designed for administration via intravenous drip.
Career Highlights
Yoshiya Iguchi is associated with Stella Pharma Corporation, where he continues to develop innovative solutions in the medical field. His work is pivotal in advancing therapeutic techniques that can improve patient outcomes.
Collaborations
Yoshiya collaborates with esteemed colleagues such as Yoshimitsu Katakuse and Hideki Nakashima. Their combined expertise contributes to the ongoing research and development efforts at Stella Pharma Corporation.
Conclusion
Yoshiya Iguchi's contributions to boron neutron capture therapy exemplify the impact of innovation in medical technology. His patent and ongoing work at Stella Pharma Corporation highlight the importance of research in improving cancer treatment methodologies.